CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

480 hedge funds and large institutions have $4.1B invested in CRISPR Therapeutics in 2024 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 158 increasing their positions, 137 reducing their positions, and 56 closing their positions.

Holders
480
Holders Change
+11
Holders Change %
+2.35%
% of All Funds
6.96%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
74
Increased
158
Reduced
137
Closed
56
Calls
$256M
Puts
$212M
Net Calls
+$44.1M
Net Calls Change
+$41M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$534M
2
EC
2
EcoR1 Capital
California
$94.7M
3
SOCM
3
SR One Capital Management
Pennsylvania
$71.5M
4
CIM
4
Contrarius Investment Management
Jersey
$45.4M
5
ACA
5
Avoro Capital Advisors
New York
$28.6M

Top Sellers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$184M
2
Voloridge Investment Management
2
Voloridge Investment Management
Florida
$3.02M
3
AIM
3
ARK Investment Management
Florida
$556M
4
Jane Street
4
Jane Street
New York
$11.9M
5
BG
5
Bellevue Group
Switzerland
$42.3M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$556M 8,157,028 -379,076 -4%
Capital International Investors
2
Capital International Investors
California
$534M 7,837,074 +1,702,624 +28%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$223M 3,268,785 -100,977 -3%
NAMA
4
Nikko Asset Management Americas
New York
$223M 3,268,785 -100,977 -3%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$184M 2,704,331 -906,855 -25%
NMC
6
NEA Management Company
Maryland
$180M 1,587,854 – –
BlackRock
7
BlackRock
New York
$174M 2,546,361 +29,875 +1%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$153M 2,239,683 +399,812 +22%
Vanguard Group
9
Vanguard Group
Pennsylvania
$112M 1,636,799 +46,148 +3%
State Street
10
State Street
Massachusetts
$102M 1,495,208 -258,289 -15%
EC
11
EcoR1 Capital
California
$94.7M 1,389,276 +1,389,276 New
Morgan Stanley
12
Morgan Stanley
New York
$74M 1,085,924 +259,770 +31%
SOCM
13
SR One Capital Management
Pennsylvania
$71.5M 1,048,951 +1,048,951 New
Loomis, Sayles & Company
14
Loomis, Sayles & Company
Massachusetts
$69.9M 1,025,243 -42,108 -4%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$63.5M 931,055 +151,601 +19%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$62M 909,298 +25,569 +3%
Bank of America
17
Bank of America
North Carolina
$58.8M 863,214 +172,044 +25%
CS
18
Credit Suisse
Switzerland
$49M 719,309 -156,836 -18%
Charles Schwab
19
Charles Schwab
California
$45.6M 669,192 +16,169 +2%
CIM
20
Contrarius Investment Management
Jersey
$45.4M 666,000 +483,073 +264%
BG
21
Bellevue Group
Switzerland
$42.3M 619,950 -280,450 -31%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$40.9M 600,234 -264,112 -31%
Norges Bank
23
Norges Bank
Norway
$40.2M 590,268 -27,318 -4%
VVM
24
Versant Venture Management
California
$34M 498,558 – –
Federated Hermes
25
Federated Hermes
Pennsylvania
$30.5M 447,606 -60,494 -12%
1
2 3 4 5